Literature DB >> 20336083

A mouse model of generalized non-Herlitz junctional epidermolysis bullosa.

Jason A Bubier1, Thomas J Sproule, Lydia M Alley, Cameron M Webb, Jo-David Fine, Derry C Roopenian, John P Sundberg.   

Abstract

Epidermolysis bullosa (EB) is a class of intractable, rare, genetic disorders characterized by fragile skin and blister formation as a result of dermal-epidermal mechanical instability. EB presents with considerable clinical and molecular heterogeneity. Viable animal models of junctional EB (JEB), that both mimic the human disease and survive beyond the neonatal period, are needed. We identified a spontaneous, autosomal recessive mutation (Lamc2(jeb)) due to a murine leukemia virus long terminal repeat insertion in Lamc2 (laminin gamma2 gene) that results in a hypomorphic allele with reduced levels of LAMC2 protein. These mutant mice develop a progressive blistering disease validated at the gross and microscopic levels to closely resemble generalized non-Herlitz JEB. The Lamc2(jeb) mice display additional extracutaneous features such as loss of bone mineralization and abnormal teeth, as well as a respiratory phenotype that is recognized but not as well characterized in humans. This model faithfully recapitulates human JEB and provides an important preclinical tool to test therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20336083      PMCID: PMC3010368          DOI: 10.1038/jid.2010.46

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  52 in total

1.  The chemical composition of tooth enamel in junctional epidermolysis bullosa.

Authors:  J Kirkham; C Robinson; S M Strafford; R C Shore; W A Bonass; S J Brookes; J T Wright
Journal:  Arch Oral Biol       Date:  2000-05       Impact factor: 2.633

2.  Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT).

Authors:  G E Truett; P Heeger; R L Mynatt; A A Truett; J A Walker; M L Warman
Journal:  Biotechniques       Date:  2000-07       Impact factor: 1.993

3.  Alternative transcriptional initiation and splicing of mouse Lamc2 message.

Authors:  G Lee; M G Kim; J B Yim; S H Hong
Journal:  Mol Cells       Date:  2001-12-31       Impact factor: 5.034

4.  Novel mutations in the LAMC2 gene in non-Herlitz junctional epidermolysis bullosa: effects on laminin-5 assembly, secretion, and deposition.

Authors:  D Castiglia; P Posteraro; F Spirito; M Pinola; C Angelo; P Puddu; G Meneguzzi; G Zambruno
Journal:  J Invest Dermatol       Date:  2001-09       Impact factor: 8.551

5.  Junctional epidermolysis bullosa in the Middle East: clinical and genetic studies in a series of consanguineous families.

Authors:  Aoi Nakano; Gilles G Lestringant; Tamar Paperna; Reuven Bergman; Ruth Gershoni; Philippe Frossard; Moien Kanaan; Guerrino Meneguzzi; Gabriele Richard; Ellen Pfendner; Jouni Uitto; Leena Pulkkinen; Eli Sprecher
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

6.  Generation of a new congenic mouse strain to test the relationships among serum insulin-like growth factor I, bone mineral density, and skeletal morphology in vivo.

Authors:  Mary L Bouxsein; Clifford J Rosen; Charles H Turner; Cheryl L Ackert; Kathryn L Shultz; Leah Rae Donahue; Gary Churchill; Martin L Adamo; David R Powell; Russell T Turner; Ralph Muller; Wesley G Beamer
Journal:  J Bone Miner Res       Date:  2002-04       Impact factor: 6.741

7.  Animal models for skin blistering conditions: absence of laminin 5 causes hereditary junctional mechanobullous disease in the Belgian horse.

Authors:  Flavia Spirito; Alexandra Charlesworth; Keith Linder; Jean-Paul Ortonne; John Baird; Guerrino Meneguzzi
Journal:  J Invest Dermatol       Date:  2002-09       Impact factor: 8.551

8.  Szt2, a novel gene for seizure threshold in mice.

Authors:  W N Frankel; Y Yang; C L Mahaffey; B J Beyer; T P O'Brien
Journal:  Genes Brain Behav       Date:  2009-07       Impact factor: 3.449

9.  Specific ablation of the nidogen-binding site in the laminin gamma1 chain interferes with kidney and lung development.

Authors:  Michael Willem; Nicolai Miosge; Willi Halfter; Neil Smyth; Iris Jannetti; Elke Burghart; Rupert Timpl; Ulrike Mayer
Journal:  Development       Date:  2002-06       Impact factor: 6.868

10.  An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy.

Authors:  T Cao; M A Longley; X J Wang; D R Roop
Journal:  J Cell Biol       Date:  2001-02-05       Impact factor: 10.539

View more
  11 in total

1.  A direct method to determine the strength of the dermal-epidermal junction in a mouse model for epidermolysis bullosa.

Authors:  Thomas J Sproule; Derry C Roopenian; John P Sundberg
Journal:  Exp Dermatol       Date:  2012-04-16       Impact factor: 3.960

Review 2.  Genetic analyses of integrin signaling.

Authors:  Sara A Wickström; Korana Radovanac; Reinhard Fässler
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

3.  A new mouse model of junctional epidermolysis bullosa: the LAMB3 628G>A knockin mouse.

Authors:  Johanna Hammersen; Jin Hou; Stephanie Wünsche; Sven Brenner; Thomas Winkler; Holm Schneider
Journal:  J Invest Dermatol       Date:  2014-10-28       Impact factor: 8.551

Review 4.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

5.  Skin fragility in the wild-derived, inbred mouse strain Mus pahari/EiJ.

Authors:  C Herbert Pratt; Christopher S Potter; Raoul V Kuiper; Son Yong Karst; Soheil S Dadras; Derry C Roopenian; John P Sundberg
Journal:  Exp Mol Pathol       Date:  2016-12-28       Impact factor: 3.362

Review 6.  Cell therapy in dermatology.

Authors:  Gabriela Petrof; Alya Abdul-Wahab; John A McGrath
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

7.  Keratinocyte-targeted expression of human laminin γ2 rescues skin blistering and early lethality of laminin γ2 deficient mice.

Authors:  Tracy L Adair-Kirk; Gail L Griffin; Michelle J Meyer; Diane G Kelley; Jeffrey H Miner; Douglas R Keene; M Peter Marinkovich; J Michael Ruppert; Jouni Uitto; Robert M Senior
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  The dysfunction of BP180/collagen XVII in keratinocytes promotes melanoma progression.

Authors:  Bin-Jin Hwang; Yang Zhang; Jaime M Brozowski; Zhen Liu; Susan Burette; Kendall Lough; Christof C Smith; Yue Shan; Jinbo Chen; Ning Li; Scott Williams; Maureen Su; Paul Googe; Nancy E Thomas; Zhi Liu
Journal:  Oncogene       Date:  2019-08-21       Impact factor: 9.867

9.  Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice.

Authors:  Thomas J Sproule; Jason A Bubier; Fiorella C Grandi; Victor Z Sun; Vivek M Philip; Caroline G McPhee; Elisabeth B Adkins; John P Sundberg; Derry C Roopenian
Journal:  PLoS Genet       Date:  2014-02-13       Impact factor: 5.917

Review 10.  Palifermin for the protection and regeneration of epithelial tissues following injury: new findings in basic research and pre-clinical models.

Authors:  Paul W Finch; Lawrence J Mark Cross; Daniel F McAuley; Catherine L Farrell
Journal:  J Cell Mol Med       Date:  2013-09       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.